FindTrial
Sign In

COMPARING THE INCIDENCE OF VENTILATOR ASSOCIATED PNEUMONIA IN MECHANICALLY VENTILATED PATIENTS BY USING THREE DIFFERENT TECHNIQUES OF BRNCHODILATION: A PROSPECTIVE OPEN LABELLED RANDOMISED CONTROL STUDY

COMPARING THE INCIDENCE OF VENTILATOR ASSOCIATED PNEUMONIA IN MECHANICALLY VENTILATED PATIENTS BY USING THREE DIFFERENT TECHNIQUES OF BRNCHODILATION: A PROSPECTIVE OPEN LABELLED RANDOMISED CONTROL STUDY - Prospective open labelled randomised controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088878
Enrollment
120
Registered
2025-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J398- Other specified diseases of upperrespiratory tract

Interventions

Intervention1: Bronchodilatation using three different techniques in mechanically ventilated patients: Three different types of intervention for broncho dilatation in patients with mechanical ventilat

Sponsors

AIIMS Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients in ICU requiring mechanical ventilatory support

Exclusion criteria

Exclusion criteria: Patients already developed VAP at the time of evaluation for inclusion in the study. Immuno-compromised patients (HIV, HBsAg positive, Leukemia, On immune suppressants).

Design outcomes

Primary

MeasureTime frame
Incidence of ventilator associated pneumonia (VAP) in patients with mechanical ventilation when three different techniques of bronchodilatation are used.Timepoint: VAP incidence during their stay in adult intensive care unit.—

Secondary

MeasureTime frame
Level of TNF alfa in bronchoalveolar lavage fluid (BAL) in all the patients. Level of CRP (C reactive protein) in blood in all the patients. Number of days bronchodilator ( i.e. nebulization/MDI/Intravenous drugs) administration required Number of ventilator free days. Length of ICU stay All-cause mortality at 28 days Timepoint: During their stay in adult intensive care unit.—

Countries

India

Contacts

Public ContactSOURAV DEY

AIIMS Jodhpur

iamfrodo48@gmail.com07001105639

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026